Trivant Custom Portfolio Group’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-100
| Closed | -$1.79K | – | 202 |
|
|
2025
Q1 | $1.79K | Buy |
+100
| New | +$1.79K | ﹤0.01% | 182 |
|
|
2023
Q4 | – | Sell |
-575
| Closed | -$5.14K | – | 217 |
|
|
2023
Q3 | $5.14K | Hold |
575
| – | – | ﹤0.01% | 179 |
|
|
2023
Q2 | $8.83K | Hold |
575
| – | – | 0.01% | 175 |
|
|
2023
Q1 | $12.9K | Buy |
+575
| New | +$12.9K | 0.01% | 173 |
|